Live Breaking News & Updates on Risk Benefits|Page 2

Stay updated with breaking news from Risk benefits. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Transcripts for BBCNEWS Outside Source 20240604 20:25:00

There s a whole host of financial questions in terms of how this will be delivered within the nhs. this drug is welcomed, it has democrat is a new strategy to help patients struggling with their weight and obesity. struggling with their weight and obesi . , , struggling with their weight and obesi . . , , ., ., obesity. and briefly, what about side effects? obesity. and briefly, what about side effects? so obesity. and briefly, what about side effects? so it s obesity. and briefly, what about side effects? so it s a side effects? so it s a pharmacological i side effects? so it s a | pharmacological agent side effects? so it s a i pharmacological agent with well known side effects. the common short term side affects is gastrointestinal distress, vomiting and lethargy. but they re also long term side effects, particularly in people who are at risk because it might adverse effects in the long term, for people on thyroid there thyroid cells. so that s why it s important to ass ....

Side Effects , Pharmacological Agent , Risk Benefits , Thyroid Cells ,

Transcripts for BBCNEWS Outside Source 20240604 19:25:00

At primary care. it is going to assess risk benefits, compliance, side effects? there s a whole host of unanswered questions in terms of how this will be delivered within the nhs. but the availability of this drug is very effective and welcoming. it provides us with a new strategy to help patients struggling with obesity. strategy to help patients struggling with obesi . , ., , . with obesity. briefly for us, what about side with obesity. briefly for us, what about side effects? with obesity. briefly for us, what about side effects? so, - with obesity. briefly for us, what about side effects? so, it s i with obesity. briefly for us, what about side effects? so, it s a i about side effects? so, it s a formal logical about side effects? so, it s a formal logical agent - about side effects? so, it s a formal logical agent with i about side effects? so, it s a - formal logical agent with well-known formal logical agent with well known side effects. the common short term side effects ....

Side Effects , Risk Benefits , Primary Care , Pancreas Cells ,

Transcripts for MSNBC The Mehdi Hasan Show 20240604 01:38:00

Eyelid drooping, and eyelid swelling. tell your doctor about your medical history. muscle or nerve conditions, and medications including botulinum toxins. as these may increase the risk of serious side effects. see for yourself at botoxcosmetic.com hi! need new glasses? as theget more from youre risk benefits at visionworks! how can you see me squinting? i can t! i m just telling everyone! hey! use your vision benefits before they expire. visionworks. see the difference. as the state of israel gets ....

Side Effects , Eyelid Swelling , Eyelid Drooping , Botulinum Toxins , Vision Benefits , Risk Benefits ,

Transcripts for CNN Anderson Cooper 360 20240604 02:46:00

Death rates about the same in both groups. but it s going to end up being a discussion with the doctor, the patient, and the family if this gets approved and to really weigh those risk benefits. it may not be applicable to people on blood thinners. so, what s the process now? so, i mean, at this point, i think if it gets approved, so, the drug company is hoping that it will get accelerated approval in january and they will apply for full approval by april. then the big question is what happens when you roll it out in the real world. does that one point difference translate to something meaningful for families. it may. giving somebody one more month, two more months, those are precious time periods where a person can function, where you can be with them, where they can recognize you. we re also going to have to see what happens in the real world. those patients in the real world are different than those in the real world. it may be costly. with aduhelm, that was about ....

Blood Thinners , Drug Group , Risk Benefits , Death Rates , Breaking Point , Drug Company , Big Question ,